July 7, 2025 · Form 4 insider transaction
Bonstein Sara bought 13,717 shares of Insmed Incorporated at $26.46 per share, a transaction worth $363.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.